Hap Trading, LLC Argenx Se Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$356.01 - $451.55 $6.69 Million - $8.49 Million	18,800 New	18,800 $118 Million
Q2 2022 Aug 12, 2022	SELL	$269.58 - $378.88 $242,622 - $340,992	-900 Reduced 6.38%	13,200 $122,000
Q1 2022 May 12, 2022	SELL	$254.45 - $351.06 $101,780 - $140,424	-400 Reduced 2.76%	14,100 $53,000
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $3.94 Million - $5.12 Million	14,500 New	14,500 $326,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.